PIN31 COST-EFFECTIVENESS ANALYSIS OF ONCEDAILY MODIFIED RELEASE CLARITHROMYCIN VERSUS CONVENTIONAL TWICE-DAILY GENERIC CLARITHROMYCIN FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS
Abstract
Authors
M Rubio S Magaz X Badia